Local delivery of mithramycin restores vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts

Journal of Controlled Release

Volumn 77, Issue 3, 2001, Pages 167-181

  Fishbein, Ilia ^a   Brauner, Ron ^b,c   Chorny, Michael ^a   Gao, Jianchuan ^a   Chen, Xing ^a   Laks, Hillel ^c   Golomb, Gershon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

Controlled release; Delivery systems; Local therapy; Mithramycin; Restenosis

Indexed keywords

BROXURIDINE; ETHYLENE VINYL ACETATE COPOLYMER; MACROGOL 4600; MACROGOL DERIVATIVE; MITHRAMYCIN; MYC PROTEIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CIRCULATION; ARTICLE; BLOOD VESSEL REACTIVITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; IMPLANT; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; RESTENOSIS; VASOCONSTRICTION; VASOMOTOR REFLEX; VEIN GRAFT;

ANIMALS; BALLOON DILATATION; CAROTID ARTERY, COMMON; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; GRAFT OCCLUSION, VASCULAR; GROWTH INHIBITORS; JUGULAR VEINS; MALE; MUSCLE, SMOOTH, VASCULAR; PLICAMYCIN; RABBITS; RATS; SWINE; TUNICA INTIMA;

EID: 0035856767     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00472-2     Document Type: Article

References (49)

1. Restenosis - An open file
2. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction
3. Significance of quiescent smooth muscle migration in the injured rat carotid artery
4. Kinetics of cellular proliferation after arterial injury IV. Heparin inhibits rat smooth muscle mitogenesis and migration
5. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo
6. Local infusion of FGF-saporin reduces intimal hyperplasia
7. Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit
8. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA
9. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
10. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb
11. Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft
12. The pathogenesis of atherosclerosis: A perspective for the 1990s
13. Triggering signaling cascades by receptor tyrosine kinases
14. Cell cycle: On target with myc
15. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides
16. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury
17. Cellular effects of antisense c-myc oligodeoxynucleotides are delivery dependent
18. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells
19. C-myc in vasculoproliferative disease
20. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters
21. Selective inhibition of c-myc expression prevents smooth muscle proliferation in response to serum
22. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats
23. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model
24. Characterization and anti-calcification effects of implantable polyurethane matrices containing amorphous dispersion of bisphosphonic acid
25. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures
26. Controlled drug release from implantable matrices based on hydrophobic polymers
27. Cultured human atherosclerotic placque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene
28. Regulation of oncogene expression in cultured aortic smooth muscle cells: Post-transcriptional control of c-myc mRNA
29. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal
30. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo
31. Proto-oncogene in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty?
32. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration
33. Morphologic and temporal analysis of vascular smooth muscle cell apoptosis induced by c-myc and E1A
34. Cell cycle dependent gene expression in quiescent, stimulated and asynchronously cycling arterial smooth muscle cells in culture
35. Differentiation of blasta from patients in myeloid crisis of chronic myelogenous leukemia by in-vivo and in-vitro plicamycin treatment
36. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action
37. Saphenous vein graft protection: Effects of c-myc antisense
38. c-MYC oncoprotein production in experimental vein graft intimal hyperplasia
39. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism
40. Determination of plicamycin in plasma by radioimmunoassay
41. Endothelial cell injury in cardiovascular surgery: The intimal hyperplastic response
42. Changes in cultured arterial smooth muscle cells isolated from chicks upon cholesterol feeding
43. Response of human coronary arteries to serotonin after injury by coronary angioplasty
44. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts
45. Alterations in serotonergic receptor expression in experimental vein grafts
46. Reduction of experimental vein graft intimal hyperplasia by ketanserin
47. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function
48. Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells